ORBIMED ADVISORS LLC – Regeneron Pharmaceuticals, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$0
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -22.2K shares | -13.12M | $688.87 | 0 |
| Q2 2022 | share | Increase | 0.00% | 22.2K shares | 13.12M | $591.13 | 22.2K |
| Q4 2021 | share | Decrease | -100.00% | -13.56K shares | -8.20M | $642.51 | 0 |
| Q3 2021 | share | Increase | 0.00% | 13.56K shares | 8.20M | $605.18 | 13.56K |
| Q3 2020 | share | Decrease | -100.00% | -30.9K shares | -19.27M | $559.78 | 0 |
| Q2 2020 | share | Increase | +79.65% | 13.7K shares | 10.87M | $623.65 | 30.9K |
| Q1 2020 | share | Decrease | -91.78% | -192.1K shares | -70.18M | $488.29 | 17.2K |
| Q4 2019 | share | Decrease | -8.24% | -18.8K shares | 15.31M | $375.48 | 209.3K |
| Q3 2019 | share | Increase | +5.70% | 12.3K shares | -4.27M | $277.4 | 228.1K |
| Q2 2019 | share | Increase | +0.47% | 1K shares | -20.65M | $313 | 215.8K |
| Q1 2019 | share | Decrease | -3.29% | -7.3K shares | 5.24M | $410.62 | 214.8K |
| Q4 2018 | share | Decrease | -43.69% | -172.3K shares | -76.39M | $373.5 | 222.1K |
| Q3 2018 | share | Increase | +5.88% | 21.9K shares | 30.84M | $404.04 | 394.4K |
| Q2 2018 | share | Decrease | -61.31% | -590.4K shares | -203.07M | $344.99 | 372.5K |
| Q1 2018 | share | Increase | +12.67% | 108.3K shares | 10.28M | $344.36 | 962.9K |
| Q4 2017 | share | Increase | +49.20% | 281.83K shares | 65.19M | $375.96 | 854.6K |
| Q3 2017 | share | Increase | +22.71% | 106K shares | 26.84M | $447.12 | 572.77K |
| Q2 2017 | share | Increase | +23.43% | 88.6K shares | 82.70M | $491.14 | 466.77K |
| Q1 2017 | share | Increase | +6.44% | 22.87K shares | 16.11M | $387.51 | 378.17K |
| Q4 2016 | share | 0.00% | 0 shares | -12.41M | $367.09 | 355.3K | |
| Q3 2016 | share | Decrease | -30.32% | -154.6K shares | -35.23M | $402.02 | 355.3K |
| Q2 2016 | share | Decrease | -4.33% | -23.1K shares | -14.04M | $349.23 | 509.9K |
| Q1 2016 | share | Increase | +10.35% | 50K shares | -70.09M | $360.44 | 533K |